Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Liftoff for the Biotech Launch Pad

    September 20, 2023

    Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

    September 19, 2023

    Machine learning biotech raises $273 million in rare successful late-stage round

    September 15, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Liftoff for the Biotech Launch Pad

      September 20, 2023

      Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

      September 19, 2023

      Machine learning biotech raises $273 million in rare successful late-stage round

      September 15, 2023

      Discover the synergy between biotech, medtech and digital health in Ghent, a European technology capital

      September 14, 2023

      Here are five biotech companies in Montreal to keep an eye on

      September 13, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»See the presentations that cutting-edge biotech companies have used to raise millions from top investors
    Bio Technology

    See the presentations that cutting-edge biotech companies have used to raise millions from top investors

    yourbiotechBy yourbiotechSeptember 29, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Over the past few years, the pandemic fueled a massive boom in biotech investing. Funding for biotech companies soared in 2021 to nearly $47 billion — a record for the industry.

    This year has marked a slowdown. As the global economy becomes more uncertain, venture capitalists have become cautious about investing in startups of all kinds — including biotech firms. Some private biotechs are delaying going public, and even preparing to raise down rounds.

    Despite the market downturn, some companies are still raising sizable funding rounds. One key to these is a great pitch deck, the presentation that companies use to solicit funding from investors. Pitch decks, also known as slide decks, usually lay out the company’s history, its achievements, and where it’s heading.

    Insider rounded up all the biotech pitch decks we’ve published, from those seeking early-stage funding to presentations for late-stage rounds, that have helped companies raise money from investors.

    In seed and Series A funding rounds, startups raise money to test their ideas

    Seed and Series A funding rounds come at the early stages of a biotech company. The company may have an idea or some preliminary clinical data, but it still needs to vet its science more thoroughly.

    Advertisement


    Some companies, such as 64x Bio, have newly identified a problem — in 64x Bio’s case, drug-manufacturing bottlenecks — and have an idea for a plan that could fix it. This is the 10-slide presentation the company used to quickly raise $55 million.

    Other startups, like the cancer-metabolism company Faeth Therapeutics, have shown promising results in lab tests and mice but not yet in humans. Check out the company’s 17-slide presentation it used to raise $47 million.

    Oftentimes, companies raising early funding rounds, like the biosensor company Monod Bio, hope the money can fund trials that will prove their science works. Monod used this 12-slide pitch deck to raise $25 million from investors.

    Read more:

    See the 11-slide presentation that sold General Catalyst on a 21-year-old founder’s at-home lab-testing platform for Latin America

    Advertisement

    See the 27-slide presentation a secretive biotech startup backed by Sean Parker used to raise $40 million and ‘open a new universe’ in cancer immunotherapy

    This 10-slide presentation convinced top VC firm NEA to invest $20 million in its first clinical-operations startup

    See the presentation microbiome startup Seed Health used to raise $40 million

    See the 10-slide presentation a Mark Cuban-backed startup used to raise $20 million to develop a vertigo headband

    By Series B funding rounds, biotech companies are trying to start human studies

    By Series B rounds, startups are often raising large sums of money and focused on growth. Many times, the companies will use new capital to hire more employees or continue to bring drugs through clinical development.

    Advertisement

    For instance, the Belgian biotech AgomAb told Insider it planned to use its new funds to extend the company’s cash runway into 2024. Here’s the 21-slide pitch deck the company used to raise $144 million from investors.

    And the genetics startup Camp4 used an 18-slide pitch deck to raise $100 million and plans to start human testing in 2023.

    The cancer startup Affini-T Therapeutics also plans to have two treatments in human testing in 2023. Here’s the 24-slide pitch deck the company used to raise $175 million from investors like Leaps by Bayer.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleNeutral Torrent Pharma; target of Rs 1500: Motilal Oswal
    Next Article Nykaa, Asian Paints, Torrent Pharma and more: Key stocks that moved the most on September 29
    yourbiotech
    • Website

    Related Posts

    Liftoff for the Biotech Launch Pad

    September 20, 2023

    Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

    September 19, 2023

    Machine learning biotech raises $273 million in rare successful late-stage round

    September 15, 2023

    Discover the synergy between biotech, medtech and digital health in Ghent, a European technology capital

    September 14, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.